Evaluation of dietary intervention in patients with hypertensive nephropathy
WANG Qikai1, MI Yanan2, LIU Hao3, LIN Jiahao4, YANG Xinyuan5, WANG Yue3, JIN Qianjing3, SONG Zhaomeng1
1. Zhucheng People's Hospital, Weifang, Shandong 262200, China; 2. School of Public Health, Binzhou Medical University, Yantai, Shandong 264003, China; 3. School of Stomatology, Binzhou Medical University, Yantai, Shandong 264003, China; 4. Weifang Vocational College of Nursing, Weifang, Shandong 262500, China; 5. The Second Clinical College of Binzhou Medical University, Yantai, Shandong 264003, China
Abstract：Objective To evaluate the effects of dietary intervention on blood pressure and renal function in patients with hypertensive nephropathy, so as to provide dietary and nutritional guidances for this population. Methods Hypertensive nephropathy patients who were treated at Zhucheng People's Hospital from March 2023 to February 2024 were selected as the study subjects and randomly divided into the intervention group and the control group. The control group received routine antihypertensive treatment and health lifestyle guidance. On the basis of the treatment and guidance received by the control group, the intervention group implemented dietary intervention in accordance with the Clinical Practice Guidelines for Nutritional Therapy of Chronic Kidney Disease in China (2021 edition) for a period of 3 months. Systolic blood pressure (SBP), diastolic blood pressure (DBP) were measured before and after the intervention, and serum creatinine (Scr), blood urea nitrogen (BUN), uric acid (UA), cystatin and β2-microglobulin were detected. Differences of indicators before and after intervention between the two groups were compared using generalized estimation equation. Results A total of 83 patients with hypertensive nephropathy were followed up, including 43 cases in the intervention group and 40 cases in the control group. There were no statistically significant differences in gender, age, body mass index, duration of hypertension, family history of hypertension, hypertension grade, physical activity index, or smoking status between the two groups (all P>0.05). The differences in SBP, DBP, Scr, BUN, and UA between the two groups, as well as the differences before and after the intervention, were statistically significant, and there was an interaction between the groups and the intervention time (all P<0.05). After intervention, the levels of SBP, DBP, Scr, BUN, and UA in the intervention group were lower than those in the control group (all P<0.05). The differences in cystatin and β2-microglobulin between the two groups and before and after the intervention were not statistically significant, and there was no interaction between the groups and the intervention time (all P>0.05). Conclusion Dietary intervention has a certain effect on reducing blood pressure and improving renal function indicators in patients with hypertensive nephropathy.
王启开, 弭亚楠, 刘好, 林嘉浩, 杨鑫源, 王越, 金千靖, 宋照猛. 高血压肾病患者膳食干预效果评价[J]. 预防医学, 2025, 37(4): 373-377.
WANG Qikai, MI Yanan, LIU Hao, LIN Jiahao, YANG Xinyuan, WANG Yue, JIN Qianjing, SONG Zhaomeng. Evaluation of dietary intervention in patients with hypertensive nephropathy. Preventive Medicine, 2025, 37(4): 373-377.
[1] EVANS P C,GIJSEN F J,WENTZEL J J,et al.Biomechanics in vascular biology and cardiovascular disease[J].Thromb Haemost,2016,115(3):465-466. [2] SIMEONI M,BORRELLI S,GAROFALO C,et al.Atherosclerotic nephropathy:an updated narrative review[J].J Nephrol,2021,34(1):125-136. [3] YANG C,GAO B X,ZHAO X J,et al.Executive summary for China kidney disease network(CK-NET)2016 annual data report[J].Kidney Int,2020,98(6):1419-1423. [4] 朱思懿,洪航,边学燕,等.慢性肾脏病流行病学研究进展[J].预防医学,2023,35(9):770-773. ZHU S Y,HONG H,BIAN X Y,et al.Research progress on the epidemiology of chronic kidney disease[J].China Prev Med J,2023,35(9):770-773.(in Chinese) [5] CHENG Y,ZHENG G H,SONG Z,et al.Association between dietary protein intake and risk of chronic kidney disease:a systematic review and meta-analysis[J/OL].Front Nutr,2024,11[2025-01-27].https://doi.org/10.3389/fnut.2024.1408424. [6] 苏彦萍,杨昆,刘相佟,等.北京市成年人群饮食行为与慢性病发病风险研究[J].预防医学,2021,33(2):111-116. SU Y P,YANG K,LIU X T,et al.Relationship between dietary behaviors and risk of noncommunicablediseases among adults in Beijing Municipality[J].China Prev Med J,2021,33(2):111-116.(in Chinese) [7] 高血压肾病诊治中国专家共识组成员.高血压肾病诊断和治疗中国专家共识(2022)[J].中华高血压杂志,2022,30(4):307-317. Members of the Chinese Expert Consensus Group on Diagnosis and Treatment of Hypertensive Nephropathy.Consensus of Chinese experts on the diagnosis and treatment of hypertensive nephropathy (2022)[J].Chin J Hypertens,2022,30(4):307-317.(in Chinese) [8] 中国医师协会肾脏内科医师分会,中国中西医结合学会肾脏疾病专业委员会营养治疗指南专家协作组.中国慢性肾脏病营养治疗临床实践指南(2021版)[J].中华医学杂志,2021,101(8):539-559. Chinese Renal Physician Branch of Chinese Medical Doctor Association,Professional Committee of Renal Diseases of the Chinese Association of Integrative Medicine Expert Collaboration Group on Nutritional Therapy Guidelines.Clinical practice guidelines for nutritional therapy in chronic kidney disease in China(2021 edition)[J].Natl Med J China,2021,101(8):539-559.(in Chinese) [9] 杨月欣. 中国食物成分表[M].北京:北京大学医学出版社,2019. YANG Y X.Chinese food composition table[M].Beijing:Peking University Medical Press,2019.(in Chinese) [10] 中国高血压防治指南修订委员会,高血压联盟(中国),中国医疗保健国际交流促进会高血压分会,等.中国高血压防治指南(2024年修订版)[J].中华高血压杂志,2024,32(7):603-700. Chinese Guidelines for the Management of Hypertension Revision Committee,Chinese Hypertension League,Hypertension Branch of China International Medical and Healthcare Exchange and Promotion Association,et al. Chinese guidelines for the management of hypertension (2024 revision)[J].Chin J Hypertens,2024,32(7):603-700.(in Chinese) [11] 杨虎,曹承松,解少煜,等.低碳水化合物饮食与血脂异常关系的横断面研究[J].营养学报,2022,44(5):442-448. YANG H,CAO C S,XIE S Y,et al.Association between low-carbohydrate diets and dyslipidemia:a population-based cross-sectional study[J].Acta Nutrimenta Sin,2022,44(5):442-448.(in Chinese) [12] 孙恕,易松.2023年《中国高血压防治指南》更新临床实践[J].心电与循环,2023,42(3):203-206,212. SUN S,YI S.Clinical practice of 2023 Hypertension Guidelines update[J].J Electrocardiol Circulation,2023,42(3):203-206,212.(in Chinese) [13] 李丽. 血清胱抑素C、同型半胱氨酸联合检测对高血压早期肾损伤的诊断价值[J].检验医学与临床,2019,16(11):1558-1560. LI L.Diagnostic value of combined detection of serum cystatin C and homocysteine in early renal injury of hypertension[J].Lab Med Clin,2019,16(11):1558-1560.(in Chinese) [14] 杨叶青,刘波,徐广平,等.氧化应激相关指标在慢性肾脏病诊断中的价值[J].预防医学,2017,29(4):338-341. YANG Y Q,LIU B,XU G P,et al.A study on the clinical value of oxidative stress related index in chronic kidney disease diagnosis[J].China Prev Med J,2017,29(4):338-341.(in Chinese) [15] 毕德成,李争,苏耀华.血清β2-MG、Hcy、NGAL、Cys C联合检测在诊断糖尿病肾病患者中的价值[J].中华保健医学杂志,2019,21(4):313-316. BI D C,LI Z,SU Y H.Application of combined detection of serum β2-MG,Hcy,NGAL and Cys C in the diagnosis of diabetic nephropathy[J].Chin Health Care Med,2019,21(4):313-316.(in Chinese)
